{
    "nctId": "NCT00910312",
    "briefTitle": "ICE-SENSE\u2122 Cryotherapy for Breast Fibroadenoma Trial",
    "officialTitle": "Evaluation of Safety and Feasibility of the ICE-SENSE\u2122, a Cryotherapy Device for Office-based Ultrasound-guided Treatment of Breast Fibroadenoma",
    "overallStatus": "COMPLETED",
    "conditions": "Fibroadenoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 54,
    "primaryOutcomeMeasure": "engulfment of the tumor by the ice-ball as seen under ultrasound imaging",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient is above 18 years old.\n* Patient has breast fibroadenoma, proven by biopsy (Core Biopsy).\n* Patient's fibroadenoma can be visualized with ultrasound.\n* Patient's fibroadenoma size is between 0.5cm and 3cm at its largest dimension.\n* Patient is able to visit the clinic as needed during the 12-month follow-up period following the cryoablation procedure.\n* The patient has been informed of the study and agrees to its provisions, and has signed an IRB/EC approved written informed consent, including data privacy authorization.\n\nExclusion Criteria:\n\n* Patients with history of breast cancer.\n* Women with known pregnancy.\n* Patients with superficial fibroadenoma very close to the skin.\n* Patient has undergone major surgery within the previous 12 weeks.\n* Patients with any terminal illness, or with a life expectancy \\<2 year.\n* Patients carrying contagious diseases such as Tuberculosis Hepatitis or AIDS.\n* Patient participating in other trials using drugs or devices.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}